Episode 411: The GLP-1 Follow-Up: Side Effects, Microdosing & Ozempic Culture

Listen on Apple Podcasts | Listen on Spotify

Ozempic culture is officially here, and after last week’s GLP-1 episode with Jessica Brown, Erin has more to say.

This time, she’s getting into the side effects practitioners are seeing and the “microdosing” marketing language that’s gotten wildly out of hand. Erin talks about the difference between using GLP-1s skillfully vs. going a little willy nilly with telehealth prescriptions, and people chasing quick weight loss without understanding what’s happening physiologically.

This is an important “part 2” conversation around why these medications can be an incredibly effective tool… while still requiring education, self-awareness, support, and a whole lot more nuance than the internet shows.


In this episode:

  • Why Erin thinks we’re wildly underprepared to use GLP-1s correctly

  • What “Ozempic culture” gets right… and where the conversation completely misses the mark

  • “Food as skinny vs. food as fuel” and why micronutrients matter more than ever if you’re on a GLP-1

  • How Erin’s client used tirzepatide without jumping to higher and higher doses

  • The GLP-1 side effects Erin is seeing most often, including SIBO flares and reflux

Resources mentioned:

Organifi Supplement Powder (save 20% on your order with code FUNK) 

OneSkin (Use code FUNK for 15% off your first purchase)

Bon Charge (Use code FUNK to save 15%)

Previous
Previous

Episode 412: The Neuroscience of Reality: Why Change Doesn’t Always Stick

Next
Next

Episode 410: GLP-1s Are Not Just About Weight Loss: Conversation with Jessica Brown